***This is a synopsis of an article published by Elsevier Ltd. written by J. Larsen, L. Broge, and H. Jacobi
Allergy Immunotherapy: The Future of Allergy Treatment
Allergic respiratory disease represents a significant and expanding problem worldwide. Allergic symptoms, such as asthma and hay fever, cause sleep impairment and reduce school and work performance. The cost to society is substantial. Allergen avoidance and pharmacotherapies, such as antihistamines, cannot control the disease. Allergy immunotherapy has disease-modifying potential and should be included in optimal treatment strategies. Allergy immunotherapy was first administered as subcutaneous injection and has been practiced over the past 100 years or so. Recently sublingual allergy immunotherapy was introduced, representing a patient-friendly concept that can be used for self-treatment at home.
Read the full article here.